以双特异性抗体 XmAb 18968 靶向 CD38 治疗复发/难治性急性髓系白血病和 T 细胞急性淋巴细胞白血病患者
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
82.5分
★★★★☆
站内排序·非疗效
FRONTIER PAPERS
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.
Gamma-delta T-cell acute lymphoblastic lymphoma/leukemia: a report of a rare entity.
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。